A citation-based method for searching scientific literature

Shilpa Thakur, Andrew Tobey, Brianna Daley, Sungyoung Auh, Mary Walter, Dhaval Patel, Naris Nilubol, Electron Kebebew, Aneeta Patel, Kirk Jensen, Vasyl Vasko, Joanna Klubo-Gwiezdzinska. Front Oncol 2019
Times Cited: 7







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cell-free nucleic acids as biomarkers in cancer patients.
Heidi Schwarzenbach, Dave S B Hoon, Klaus Pantel. Nat Rev Cancer 2011
57

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
42

Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification.
Francesca Salvianti, Corinna Giuliani, Luisa Petrone, Irene Mancini, Vania Vezzosi, Cinzia Pupilli, Pamela Pinzani. Int J Mol Sci 2017
25
42

Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma.
C Pupilli, P Pinzani, F Salvianti, B Fibbi, M Rossi, L Petrone, G Perigli, M L De Feo, V Vezzosi, M Pazzagli,[...]. J Clin Endocrinol Metab 2013
40
42

Circulating nucleic acids (CNAs) and cancer--a survey.
M Fleischhacker, B Schmidt. Biochim Biophys Acta 2007
622
42

Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer.
Shimaa El-Shafey Soliman, Alshimaa Mahmoud Alhanafy, Mona Salah El-Din Habib, Mohamed Hagag, Reda Abdel Latif Ibrahem. Biochem Biophys Rep 2018
25
42

Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Benjamin Arko-Boham, Nii Ayite Aryee, Richard Michael Blay, Ewurama Dedea Ampadu Owusu, Emmanuel Ayitey Tagoe, Eshirow-Sam Doris Shackie, Ama Boatemaa Debrah, Nii Armah Adu-Aryee. Cancer Genet 2019
26
42

Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence.
Amal Fawzy, Karima M Sweify, Hany M El-Fayoumy, Nagwa Nofal. J Egypt Natl Canc Inst 2016
33
42

Increased DNA integrity in colorectal cancer.
Gloria Leszinski, Julia Lehner, Ugur Gezer, Stefan Holdenrieder. In Vivo 2014
19
42

Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer.
Sobuhi Iqbal, Sreenivas Vishnubhatla, Vinod Raina, Surabhi Sharma, Ajay Gogia, Suryanarayana S V Deo, Sandeep Mathur, Nutan Kumar Shukla. Springerplus 2015
43
42

Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer.
Mariangela Zane, Marco Agostini, Maria Vittoria Enzo, Eric Casal Ide, Paola Del Bianco, Francesca Torresan, Isabella Merante Boschin, Gianmaria Pennelli, Andrea Saccani, Domenico Rubello,[...]. Biomed Pharmacother 2013
40
28

Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Heidi Schwarzenbach, Jan Stoehlmacher, Klaus Pantel, Eray Goekkurt. Ann N Y Acad Sci 2008
125
28

Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
Jie Cheng, Qiuqiong Tang, Xue Cao, Barbara Burwinkel. Cancer Epidemiol Biomarkers Prev 2017
26
28

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.
S Jahr, H Hentze, S Englisch, D Hardt, F O Fackelmayer, R D Hesch, R Knippers. Cancer Res 2001
28


Increased plasma DNA integrity in cancer patients.
Brant G Wang, Han-Yao Huang, Yu-Chi Chen, Robert E Bristow, Keyanunoosh Kassauei, Chih-Chien Cheng, Richard Roden, Lori J Sokoll, Daniel W Chan, Ie-Ming Shih. Cancer Res 2003
244
28

Assessment of circulating serum DNA integrity in colorectal cancer patients.
Ebru E Yörüker, Emre Özgür, Metin Keskin, Nejat Dalay, Stefan Holdenrieder, Ugur Gezer. Anticancer Res 2015
10
28

Methods for isolation of cell-free plasma DNA strongly affect DNA yield.
Michael Fleischhacker, Bernd Schmidt, Sabine Weickmann, Debora M I Fersching, Gloria S Leszinski, Barbara Siegele, Oliver J Stötzer, Dorothea Nagel, Stefan Holdenrieder. Clin Chim Acta 2011
78
28

Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
Marco Agostini, Salvatore Pucciarelli, Maria Vittoria Enzo, Paola Del Bianco, Marta Briarava, Chiara Bedin, Isacco Maretto, Maria Luisa Friso, Sara Lonardi, Claudia Mescoli,[...]. Ann Surg Oncol 2011
84
28


Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy.
Ugur Deligezer, Yesim Eralp, Ebru E Akisik, Elif Z Akisik, Pinar Saip, Erkan Topuz, Nejat Dalay. Clin Chem Lab Med 2008
35
28

Increased Free Circulating DNA Integrity Index as a Serum Biomarker in Patients with Colorectal Carcinoma.
Dina El-Gayar, Nevine El-Abd, Noha Hassan, Reem Ali. Asian Pac J Cancer Prev 2016
22
28

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma.
Ao Huang, Xin Zhang, Shao-Lai Zhou, Ya Cao, Xiao-Wu Huang, Jia Fan, Xin-Rong Yang, Jian Zhou. J Cancer 2016
43
28

Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care.
Safia El Messaoudi, Florent Mouliere, Stanislas Du Manoir, Caroline Bascoul-Mollevi, Brigitte Gillet, Michelle Nouaille, Catherine Fiess, Evelyne Crapez, Frederic Bibeau, Charles Theillet,[...]. Clin Cancer Res 2016
108
28

Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
Naoyuki Umetani, Joseph Kim, Suzanne Hiramatsu, Howard A Reber, Oscar J Hines, Anton J Bilchik, Dave S B Hoon. Clin Chem 2006
226
28

Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
Jie Cheng, Tim Holland-Letz, Markus Wallwiener, Harald Surowy, Katarina Cuk, Sarah Schott, Andreas Trumpp, Klaus Pantel, Christof Sohn, Andreas Schneeweiss,[...]. Breast Cancer Res Treat 2018
36
28

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
Dharanija Madhavan, Markus Wallwiener, Karin Bents, Manuela Zucknick, Juliane Nees, Sarah Schott, Katarina Cuk, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel,[...]. Breast Cancer Res Treat 2014
108
28

Integrity of plasma cell-free DNA as a prognostic factor for vaccine therapy in patients with endometrial cancer.
Kayoko Waki, Kanako Yokomizo, Kouichiro Kawano, Naotake Tsuda, Nobukazu Komatsu, Akira Yamada. Mol Clin Oncol 2021
2
100

Serum DNA integrity index as a potential molecular biomarker in endometrial cancer.
Enrico Vizza, Giacomo Corrado, Martina De Angeli, Mariantonia Carosi, Emanuela Mancini, Ermelinda Baiocco, Benito Chiofalo, Lodovico Patrizi, Ashanti Zampa, Giulia Piaggio,[...]. J Exp Clin Cancer Res 2018
31
28

Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer.
Neveen A Hussein, Salwa N Mohamed, Mohamed A Ahmed. Appl Biochem Biotechnol 2019
23
28

Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.
Julia Lehner, Oliver J Stötzer, Debora Fersching, Dorothea Nagel, Stefan Holdenrieder. Clin Chim Acta 2013
29
28

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.
Jie Cheng, Katarina Cuk, Jörg Heil, Michael Golatta, Sarah Schott, Christof Sohn, Andreas Schneeweiss, Barbara Burwinkel, Harald Surowy. Oncotarget 2017
22
28

Initial sequencing and analysis of the human genome.
E S Lander, L M Linton, B Birren, C Nusbaum, M C Zody, J Baldwin, K Devon, K Dewar, M Doyle, W FitzHugh,[...]. Nature 2001
28

Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
Chiara Bedin, Maria Vittoria Enzo, Paola Del Bianco, Salvatore Pucciarelli, Donato Nitti, Marco Agostini. Int J Cancer 2017
62
28


Alu cell-free DNA concentration, Alu index, and LINE-1 hypomethylation as a cancer predictor.
Min-Koo Park, Jeong-Chan Lee, Ji-Won Lee, Sung-Joo Hwang. Clin Biochem 2021
5
40

Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
M Agostini, M V Enzo, C Bedin, V Belardinelli, E Goldin, P Del Bianco, E Maschietto, E D'Angelo, Leo Izzi, A Saccani,[...]. Cancer Biomark 2012
56
28

Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.
Feng Zhu, Jing Ma, Dongdong Ru, Ningning Wu, Yunhua Zhang, Huiyuan Li, Xiaoli Liu, Jianfeng Li, Huiling Zhang, Yue Xu,[...]. J Oncol 2021
2
100

Prognostic value of the DNA integrity index in patients with malignant lung tumors.
Dimple Y Chudasama, Zeynep Aladag, Mayla I Felicien, Marcia Hall, Julie Beeson, Nizar Asadi, Yori Gidron, Emmanouil Karteris, Vladimir B Anikin. Oncotarget 2018
10
28

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.
T B Hao, W Shi, X J Shen, J Qi, X H Wu, Y Wu, Y Y Tang, S Q Ju. Br J Cancer 2014
124
28

Clinical value of ALU concentration and integrity index for the early diagnosis of ovarian cancer: A retrospective cohort trial.
Rong Zhang, Wangyang Pu, Shuyun Zhang, Li Chen, Weipei Zhu, Li Xiao, Chungen Xing, Kai Li. PLoS One 2018
17
28

Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
Shaoyi Leng, Jianjun Zheng, Yinhua Jin, Hongbin Zhang, Ya Zhu, Jing Wu, Yan Xu, Puhong Zhang. Clin Chim Acta 2018
19
28

Long noncoding RNAs in thyroid cancer.
Mahsa Sedaghati, Electron Kebebew. Curr Opin Endocrinol Diabetes Obes 2019
23
14


Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer.
Zhong-Ling Qiu, Wei-Jun Wei, Zhen-Kui Sun, Chen-Tian Shen, Hong-Jun Song, Xin-Yun Zhang, Guo-Qiang Zhang, Xiao-Yue Chen, Quan-Yong Luo. Cell Physiol Biochem 2018
21
14

Detection of plasma BRAF(V600E) mutation is associated with lung metastasis in papillary thyroid carcinomas.
Bo Hyun Kim, In Joo Kim, Byung Joo Lee, Jin Choon Lee, In Suk Kim, Seong-Jang Kim, Won Jin Kim, Yun Kyung Jeon, Sang Soo Kim, Yong Ki Kim. Yonsei Med J 2015
29
14

Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
Giovanni Ponti, Marco Manfredini, Aldo Tomasi. Crit Rev Oncol Hematol 2019
33
14

Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer.
Jen-Der Lin, Miaw-Jene Liou, Hsueh-Ling Hsu, Kong-Kit Leong, Yu-Ting Chen, Ying-Ru Wang, Wei-Shan Hung, Hsing-Ying Lee, Hui-Ju Tsai, Ching-Ping Tseng. Thyroid 2018
13
14

Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Jicheng Wu, Shen Hu, Lihong Zhang, Jinxia Xin, Chongran Sun, Liquan Wang, Kefeng Ding, Ben Wang. Theranostics 2020
45
14

Non-invasive Molecular Detection of Minimal Residual Disease in Papillary Thyroid Cancer Patients.
Hannah Almubarak, Ebtesam Qassem, Lamyaa Alghofaili, Ali S Alzahrani, Bedri Karakas. Front Oncol 2020
7
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.